Evaluating immune-related adverse events (irAEs) in a real-world cohort with lung cancer receiving immunotherapy

被引：0
|
作者：
Hu, Xiao [1 ]
Pan, Stacey [1 ]
Salei, Yana V. [2 ]
Lin, Jeffrey H. [2 ]
Parsons, Susan K. [1 ,3 ]
机构：
[1] Tufts Med Ctr, Div Hematol Oncol, Dept Med, Boston, MA USA
[2] Tufts Med Ctr, Dept Med, Boston, MA USA
[3] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PP01.67
引用
收藏
页码：E32 / E32
页数：1
相关论文
共 50 条
  • [21] Association of immune-related adverse events (irAEs) and immunotherapy (IT) benefit in advanced non-small cell lung cancer (NSCLC)
    Saavedra Serrano, C.
    Barquin Garcia, A.
    Corral de la Fuente, E.
    Serrano Domingo, J. J.
    Albarran Artahona, V.
    Martin Huertas, R.
    Gomez Rueda, A.
    Olmedo Garcia, M. E.
    ANNALS OF ONCOLOGY, 2019, 30
  • [22] Immune-Related Adverse Events Due to Cancer Immunotherapy
    Benesova, Karolina
    Leipe, Jan
    AKTUELLE RHEUMATOLOGIE, 2020, 45 (06) : 535 - 543
  • [23] Testing Immune-Related Adverse Events in Cancer Immunotherapy
    Farmer, Jocelyn R.
    CLINICS IN LABORATORY MEDICINE, 2019, 39 (04) : 669 - +
  • [24] The Impact of Body Mass Index on Immune-Related Adverse Events and Outcomes in Patients with Lung Cancer: A Real-World Study
    Hu, X.
    Gurinovich, A.
    Pan, S.
    Salei, Y. V.
    Lin, J. H.
    Rodday, A. M.
    Parsons, S. K.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S611 - S612
  • [25] Real-world incidence and outcomes of immune-related adverse events in NSCLC patients
    Knox, A.
    Cloney, T.
    Janssen, H.
    Solomon, B.
    Alexander, M.
    John, T.
    ANNALS OF ONCOLOGY, 2023, 34 : S1684 - S1684
  • [26] Real-World Adherence to Toxicity Management Guidelines for Immune-Related Adverse Events
    Teimouri, Arezou
    Minard, Laura, V
    Scott, Samantha N.
    Daniels, Amanda
    Snow, Stephanie
    CURRENT ONCOLOGY, 2022, 29 (05) : 3104 - 3117
  • [27] Acknowledging and addressing real-world challenges to treating immune-related adverse events
    von Itzstein, Mitchell S.
    Gerber, David E.
    Bermas, Bonnie L.
    Meara, Alexa
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (07)
  • [28] The Price of Success: Immune-Related Adverse Events from Immunotherapy in Lung Cancer
    Coschi, Courtney H.
    Juergens, Rosalyn A.
    CURRENT ONCOLOGY, 2021, 28 (06) : 4392 - 4407
  • [29] Association of antibiotic treatment with immune-related adverse events in patients with cancer receiving immunotherapy
    Jing, Ying
    Chen, Xue
    Li, Kunyan
    Liu, Yaoming
    Zhang, Zhao
    Chen, Yiqing
    Liu, Yuan
    Wang, Yushu
    Lin, Steven H.
    Diao, Lixia
    Wang, Jing
    Lou, Yanyan
    Johnson, Douglas B.
    Chen, Xiang
    Liu, Hong
    Han, Leng
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (01)
  • [30] Immune-Related Adverse Events (irAEs) of Nivolumab Predicts Clinical Benefit in Advanced Lung Cancer Patients
    Toi, Y.
    Sugawara, S.
    Kawashima, Y.
    Aiba, T.
    Tsurumi, K.
    Suzuki, K.
    Shimizu, H.
    Sugisaka, J.
    Ono, H.
    Domeki, Y.
    Kawana, S.
    Saito, R.
    Terayama, K.
    Nakamura, A.
    Yamanda, S.
    Kimura, Y.
    Honda, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2417 - S2417
12345